Viatris, Inc. (VTRS)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Apr 25, 2025

$8.13

P/E Ratio

N/A

Market Cap

$9.7B

Loading...
Description
Add to research
View more

Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Metrics
Add to research
View more

Overview

  • HQCanonsburg, PA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerVTRS
  • Price$8.13+1.25%

Trading Information

  • Market cap$9.70B
  • Float97.44%
  • Average Daily Volume (1m)13,541,029
  • Average Daily Volume (3m)14,382,452
  • EPS-$0.53

Company

  • Revenue$14.71B
  • Rev growth (1yr)-4.37%
  • Net income-$634.20M
  • Gross margin42.32%
  • EBITDA margin31.06%
  • EBITDA$4.57B
  • EV$28.34B
  • EV/Revenue1.93
  • P/EN/A
  • P/S0.66
  • P/B0.52
  • Debt/Equity76.81
Documents
Add to research
View more
Factset Street Account
Wikipedia